Cite

HARVARD Citation

    Aggarwal, D. et al. (2022). P2Y12 inhibitor versus aspirin monotherapy for secondary prevention of cardiovascular events: meta-analysis of randomized trials. European Heart Journal Open. 2 (2), p. . [Online]. 
  
Back to record